Literature DB >> 34915031

How to investigate human health effects related to exposure to mixtures of per- and polyfluoroalkyl substances: A systematic review of statistical methods.

Isabella Rosato1, Maryam Zare Jeddi2, Caterina Ledda3, Elisa Gallo1, Tony Fletcher4, Gisella Pitter5, Erich Batzella1, Cristina Canova6.   

Abstract

BACKGROUND: Humans are exposed to several per- and polyfluoroalkyl substances (PFAS) daily; however, most previous studies have focused on individual PFAS. Although attention to effects of exposure to mixtures of PFAS has grown in recent years, there is no consensus on the appropriate statistical methods that can be used to assess their combined effect on human health.
OBJECTIVES: We aim to perform a comprehensive review of the statistical methods used in the existing studies which evaluate the association between exposure to mixtures of PFAS and any adverse human health effect.
METHODS: The online databases PubMed, Embase and Scopus were searched for eligible studies, published during the last ten years (last search performed on April 08, 2021). Covidence software was used by two different reviewers to perform a title/abstract screening, followed by a full text revision of the selected papers.
RESULTS: A total of 3640 papers were identified, and after the screening process, 53 papers were included in the current review. Most of the studies were published between 2019 and 2021 and were conducted mainly in North America and Europe; more than half of the studies (28 out of 53) were conducted on mother and child pairs. WQS (Weighted Quantile Sum) Regression and BKMR (Bayesian Kernel Machine Regression) were used in 36 out of 53 papers to model mixtures' effects. Health outcomes included in the studies are immunotoxicity (n = 8), fetal development (n = 7), neurodevelopment (n = 9), reproductive hormones (n = 6), thyroid hormones (n = 7), outcomes related to metabolic pathways (n = 16).
CONCLUSION: Studies on human exposure to PFAS as complex mixtures and health consequences have substantially increased in the last few years. Based on our findings, we propose that addressing risk from PFAS mixtures will likely require combinations of approaches and implementation of constantly evolving statistical methods. Specific guidelines and tools for quality assessment and publication of mixture observational studies are warranted.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemical mixtures; Environmental exposure; Human health; Joint effect; per- and polyfluoroalkyl substances (PFAS)

Mesh:

Substances:

Year:  2021        PMID: 34915031     DOI: 10.1016/j.envres.2021.112565

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  4 in total

1.  Association of Rare Earth Elements with Passive Smoking among Housewives in Shanxi Province, China.

Authors:  Jigen Na; Huiting Chen; Hang An; Nan Li; Lailai Yan; Rongwei Ye; Zhiwen Li
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

2.  Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence.

Authors:  Andreas-Marius Kaiser; Maryam Zare Jeddi; Maria Uhl; Florence Jornod; Mariana F Fernandez; Karine Audouze
Journal:  Toxics       Date:  2022-08-04

3.  Associations between Mixture of Perfluoroalkyl Substances and Lipid Profile in a Highly Exposed Adult Community in the Veneto Region.

Authors:  Erich Batzella; Maryam Zare Jeddi; Gisella Pitter; Francesca Russo; Tony Fletcher; Cristina Canova
Journal:  Int J Environ Res Public Health       Date:  2022-09-29       Impact factor: 4.614

Review 4.  Epidemiology Evidence for Health Effects of 150 per- and Polyfluoroalkyl Substances: A Systematic Evidence Map.

Authors:  Elizabeth G Radke; J Michael Wright; Krista Christensen; Cynthia J Lin; Alexandra E Goldstone; Courtney Lemeris; Kristina A Thayer
Journal:  Environ Health Perspect       Date:  2022-09-30       Impact factor: 11.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.